Gail Dee Ann Young, SPEECH Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 W 4th Ter, Trenton, MO 64683 Phone: 660-359-2228 Fax: 660-359-3995 |
News Archive
Ingenza is pleased to announce it has successfully applied for EU H2020 SME Instrument funding of €50,000 for Phase 1 of its innovative SYNBIOMAN project, allowing the company to forge ahead with the development of this novel synthetic biology-driven biomanufacturing platform. Successful completion of the Phase 1 study could open the door to additional funding for Phase 2, valued at €2.5 million.
President Barack Obama uses the new enrollment numbers to urge Democrats to be proud of the health law and call on Republicans to back off in their push to repeal the measure. GOP leaders, though, did not appear to soften their positions
Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute report a discovery that helps scientists understand why some tumors lack immune cell infiltration and are therefore unresponsive to newer PD-1 targeted therapies.
Researchers from Brazil and Texas have started testing on humans a new strategy to increase the effectiveness of topical anesthesia used in dentistry, used by dentists to reduce patient discomfort during the application of injected anesthesia - required for more invasive procedures such as fillings, tooth extraction or surgery.
Allergan, Inc. today announced that the United States Food and Drug Administration (FDA) has approved OZURDEX (dexamethasone intravitreal implant) 0.7 mg for the treatment of non-infectious ocular inflammation, or uveitis, affecting the posterior segment of the eye.
› Verified 3 days ago